title: Current management of hepatocellular carcinoma.
abstract: Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and leading cause of death among patients with cirrhosis. Treatment guidelines are based according to the Barcelona Clinic Liver Cancer staging system. The choice among therapeutic options that include liver resection, liver transplantation, locoregional, and systemic treatments must be individualized for each patient. The aim of this paper is to review the outcomes that can be achieved in the treatment of HCC with the heterogeneous therapeutic options currently available in clinical practice.
authors.affiliation: Parissa Tabrizian, Sasan Roayaie, Myron E Schwartz, Mount Sinai Liver Cancer Program, Mount Sinai Medical Center, New York, NY 10029, United States.
authors.forename: Parissa
authors.initials: P
authors.lastname: Tabrizian
authors.affiliation: Parissa Tabrizian, Sasan Roayaie, Myron E Schwartz, Mount Sinai Liver Cancer Program, Mount Sinai Medical Center, New York, NY 10029, United States.
authors.forename: Sasan
authors.initials: S
authors.lastname: Roayaie
authors.affiliation: Parissa Tabrizian, Sasan Roayaie, Myron E Schwartz, Mount Sinai Liver Cancer Program, Mount Sinai Medical Center, New York, NY 10029, United States.
authors.forename: Myron E
authors.initials: ME
authors.lastname: Schwartz
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D006498:Hepatectomy / Q000009:adverse effects / Q000401:mortality / Q000592:standards; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D016031:Liver Transplantation / Q000009:adverse effects / Q000401:mortality / Q000592:standards; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents
keywords: Barcelona Clinic Liver Cancer guidelines; Hepatocellular carcinoma; Management; Outcome; Therapeutic options